Download PDF
Hamostaseologie 2021; 41(05): 400-402
DOI: 10.1055/a-1554-6390
Case Report

Extensive Thromboembolism in a Young Male with Asymptomatic COVID-19 Infection and Heterozygous Factor V Leiden Mutation

Florian Appenzeller
1   Department of Cardiology and Angiology, University Hospital Tübingen, Tübingen, Germany
,
Jörg Schmehl
2   Department of Radiology, University Hospital Tübingen, Tübingen, Germany
,
Meinrad Gawaz
1   Department of Cardiology and Angiology, University Hospital Tübingen, Tübingen, Germany
,
Iris Müller
1   Department of Cardiology and Angiology, University Hospital Tübingen, Tübingen, Germany
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

In this case report we present a previously healthy 21-year-old male with extensive thromboembolism in the setting of asymptomatic COVID-19 infection and heterozygous factor V Leiden mutation with no additional thrombophilic risk factors.

Keywords

asymptomatic COVID-19 - factor V Leiden - thromboembolism


Publication History

Received: 03 May 2021

Accepted: 19 July 2021

Article published online:
07 September 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Watson L, Broderick C, Armon MP. Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev 2016; 11: CD002783
    PubMedGoogle Scholar
  • 2 Stefely JA, Christensen BB, Gogakos T. et al. Marked factor V activity elevation in severe COVID-19 is associated with venous thromboembolism. Am J Hematol 2020; 95 (12) 1522-1530
    CrossrefPubMedGoogle Scholar
  • 3 Zhang J, He Y, Song W. et al. Lack of association between factor V Leiden and sepsis: a meta-analysis. Clin Appl Thromb Hemost 2015; 21 (03) 204-210
    CrossrefPubMedGoogle Scholar